Points to consider in the design and submission of human somatic cell gene therapy protocols.
D026683:Advisory Committees; D032761:Animal Experimentation; D002986:Clinical Trials as Topic; D004274:DNA, Recombinant / Q000627:therapeutic use*; D028744:Ethics Committees, Research; D004992:Ethics, Medical; D035082:Federal Government; D005796:Genes; D005818:Genetic Engineering; D033161:Government Regulation; D006801:Humans; D033181:Information Dissemination; D009316:National Institutes of Health (U.S.); D018579:Patient Selection; D035842:Research Subjects; D018570:Risk Assessment; D014481:United States
D004274:DNA, Recombinant